These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 18243675)

  • 21. Studying MHC class I peptide loading and exchange in vitro.
    Bouvier M
    Methods Mol Biol; 2013; 960():81-91. PubMed ID: 23329480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of protective antitumor immunity through attenuation of ERAAP function.
    James E; Bailey I; Sugiyarto G; Elliott T
    J Immunol; 2013 Jun; 190(11):5839-46. PubMed ID: 23610143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Constraints within major histocompatibility complex class I restricted peptides: presentation and consequences for T-cell recognition.
    Theodossis A; Guillonneau C; Welland A; Ely LK; Clements CS; Williamson NA; Webb AI; Wilce JA; Mulder RJ; Dunstone MA; Doherty PC; McCluskey J; Purcell AW; Turner SJ; Rossjohn J
    Proc Natl Acad Sci U S A; 2010 Mar; 107(12):5534-9. PubMed ID: 20212169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alternative pathways for processing exogenous and endogenous antigens that can generate peptides for MHC class I-restricted presentation.
    Reimann J; Schirmbeck R
    Immunol Rev; 1999 Dec; 172():131-52. PubMed ID: 10631943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accessory molecules in the assembly of major histocompatibility complex class I/peptide complexes: how essential are they for CD8(+) T-cell immune responses?
    Garbi N; Tanaka S; van den Broek M; Momburg F; Hämmerling GJ
    Immunol Rev; 2005 Oct; 207():77-88. PubMed ID: 16181328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peptide exchange in MHC molecules.
    Jensen PE; Weber DA; Thayer WP; Westerman LE; Dao CT
    Immunol Rev; 1999 Dec; 172():229-38. PubMed ID: 10631949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exogenous peptides enter the endoplasmic reticulum of TAP-deficient cells and induce the maturation of nascent MHC class I molecules.
    Levitt JM; Howell DD; Rodgers JR; Rich RR
    Eur J Immunol; 2001 Apr; 31(4):1181-90. PubMed ID: 11298343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MHC class I antigen presentation--recently trimmed and well presented.
    Flutter B; Gao B
    Cell Mol Immunol; 2004 Feb; 1(1):22-30. PubMed ID: 16212917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis C virus envelope glycoprotein E1 originates in the endoplasmic reticulum and requires cytoplasmic processing for presentation by class I MHC molecules.
    Selby M; Erickson A; Dong C; Cooper S; Parham P; Houghton M; Walker CM
    J Immunol; 1999 Jan; 162(2):669-76. PubMed ID: 9916684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endoplasmic reticulum aminopeptidase 1 (ERAP1) trims MHC class I-presented peptides in vivo and plays an important role in immunodominance.
    York IA; Brehm MA; Zendzian S; Towne CF; Rock KL
    Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9202-7. PubMed ID: 16754858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of the role of bleomycin hydrolase in antigen presentation and the generation of CD8 T cell responses.
    Towne CF; York IA; Watkin LB; Lazo JS; Rock KL
    J Immunol; 2007 Jun; 178(11):6923-30. PubMed ID: 17513741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ER aminopeptidases generate a unique pool of peptides for MHC class I molecules.
    Serwold T; Gaw S; Shastri N
    Nat Immunol; 2001 Jul; 2(7):644-51. PubMed ID: 11429550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MHC I chaperone complexes shaping immunity.
    Thomas C; Tampé R
    Curr Opin Immunol; 2019 Jun; 58():9-15. PubMed ID: 30771631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of MHC class I-restricted antigen processing and cross-presentation.
    Cresswell P; Ackerman AL; Giodini A; Peaper DR; Wearsch PA
    Immunol Rev; 2005 Oct; 207():145-57. PubMed ID: 16181333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nowhere to hide: unconventional translation yields cryptic peptides for immune surveillance.
    Starck SR; Shastri N
    Immunol Rev; 2016 Jul; 272(1):8-16. PubMed ID: 27319338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for successive peptide binding and quality control stages during MHC class I assembly.
    Lewis JW; Elliott T
    Curr Biol; 1998 Jun; 8(12):717-20. PubMed ID: 9637925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation, translocation, and presentation of MHC class I-restricted peptides.
    Heemels MT; Ploegh H
    Annu Rev Biochem; 1995; 64():463-91. PubMed ID: 7574490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cross-presentation of peptides from intracellular pathogens by MHC class I molecules.
    Blanchard N; Shastri N
    Ann N Y Acad Sci; 2010 Jan; 1183():237-50. PubMed ID: 20146719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assembly and transport of class I MHC-peptide complexes.
    Cresswell P; Androlewicz MJ; Ortmann B
    Ciba Found Symp; 1994; 187():150-62; discussion 162-9. PubMed ID: 7796669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peptide Trimming for MHC Class I Presentation by Endoplasmic Reticulum Aminopeptidases.
    Compagnone M; Fruci D
    Methods Mol Biol; 2019; 1988():45-57. PubMed ID: 31147931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.